Marco Salvetti

Pubblicazioni

Titolo	Pubblicato in	Anno
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis	ANNALS OF NEUROLOGY	2021
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis	JOURNAL OF NEUROLOGY	2021
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up	JOURNAL OF NEUROLOGY	2021
Circulating hsa-miR-323b-3p in Huntington's Disease. A Pilot Study	FRONTIERS IN NEUROLOGY	2021
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation	NEUROLOGICAL SCIENCES	2021
Mait cells and microbiota in multiple sclerosis and other autoimmune diseases	MICROORGANISMS	2021
A case of double standard. Sex differences in multiple sclerosis risk factors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2021
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate	FRONTIERS IN NEUROLOGY	2021
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY	2021
DMTs and Covid-19 severity in MS. a pooled analysis from Italy and France	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY	2021
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP	NEUROLOGICAL SCIENCES	2021
Validation of the Canadian occupational performance measure in Italian Parkinson’s disease clients	PHYSICAL & OCCUPATIONAL THERAPY IN GERIATRICS	2021
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials	EUROPEAN JOURNAL OF NEUROLOGY	2021
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?	FRONTIERS IN IMMUNOLOGY	2021
A single-agent extension of the SIR model describes the impact of mobility restrictions on the COVID-19 epidemic	SCIENTIFIC REPORTS	2021
Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint	CURRENT NEUROPHARMACOLOGY	2021
ADEM after ChAdOx1 nCoV-19 vaccine: A case report	MULTIPLE SCLEROSIS	2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis	EUROPEAN JOURNAL OF NEUROLOGY	2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies	EBIOMEDICINE	2021

Pubblicazioni

Progetti di Ricerca